Empagliflozin reduces brain pathology in Alzheimer's disease and type 2 diabetes

Division of Physiology, School of Medicine, Universidad de Cadiz, Cadiz, Spain (Hierro-Bujalance C, Garcia-Alloza M) Instituto de Investigacion e Innovacion en Ciencias Biomedicas de la Provincia de Cadiz (INIBICA), Cadiz, Spain (Hierro-Bujalance C, Garcia-Alloza M) Salus Infirmorum-Universidad de Cadiz, Cadiz, Spain (Hierro-Bujalance C) *Correspondence to: Monica Garcia-Alloza, PhD, [email protected]. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.